5 Stocks Under Wall Street’s Radar: Comcast (NASDAQ:CMCSA), SandRidge Energy (NYSE:SD), Elizabeth Arden (NASDAQ:RDEN), BlackRock Capital Investment (NASDAQ:BKCC), Valeant Pharmaceuticals Intl (NYSE:VRX)

On 4 August, Comcast Corporation (NASDAQ:CMCSA) said that it would expand the $9.95-a-month program to low-income senior citizens. Comcast Corporation (NASDAQ:CMCSA) belongs to Services sector. Its net profit margin is 12.30% and weekly performance is -5.75%. On last trading day company shares ended up $58.82. Comcast Corporation (NASDAQ:CMCSA) distance from 50-day simple moving average (SMA50) is -3.52%.

On 5 August, SandRidge Energy, Inc. (NYSE:SD) announced that it has appointed Julian Bott as Executive Vice President and Chief Financial Officer of the company. SandRidge Energy, Inc. (NYSE:SD) shares moved down -9.76% in last trading session and ended the day at $0.50. SD Gross Margin is 65.80% and its return on assets is -12.40%. SandRidge Energy, Inc. (NYSE:SD) quarterly performance is -68.98%.

On 6 August, Elizabeth Arden, Inc. (NASDAQ:RDEN) announced financial results for its fourth quarter and year ended June 30, 2015. Net sales for the fiscal quarter ended June 30, 2015, were $175.5 million. On an adjusted basis, net sales were $188.7 million, a decrease of 6.2% from the prior year, or 0.7% at constant foreign currency rates. The net loss per diluted share for the fiscal quarter ended June 30, 2015, was $3.65. On 07 August, Elizabeth Arden, Inc. (NASDAQ:RDEN) shares remains unchanged and was closed at $9.90. RDEN EPS growth in last 5 year was 12.03%. Elizabeth Arden, Inc. (NASDAQ:RDEN) year to date (YTD) performance is -53.72%.

Zacks upgraded shares of BlackRock Capital Investment Corporation (NASDAQ:BKCC) from a strong sell rating to a hold rating in a report released on Tuesday. Zacks currently has $10.00 price objective on the stock. BlackRock Capital Investment Corporation (NASDAQ:BKCC) ended the last trading day at $9.39. Company weekly volatility is calculated as 2.00% and price to cash ratio as 15.48. BlackRock Capital Investment Corporation (NASDAQ:BKCC) showed a weekly performance of -0.63%.

On 23 July, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) reported a better-than-expected quarterly profit, helped by strength in its dermatology business in the United States. Valeant said it expects 2015 revenue of $10.7-billion-$11.1-billion, up from its $10.4-billion-$10.6-billion. It also raised its adjusted profit forecast to $11.50-$11.80 per share, from $10.90-$11.20.Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares moved down -0.25% in last trading session and ended the day at $247.79. VRX Gross Margin is 74.00% and its return on assets is 2.40%. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) quarterly performance is 11.68%.

Leave a Reply

Your email address will not be published. Required fields are marked *